Walleye Trading
AZN icon

Walleye Trading’s AstraZeneca AZN Stock Holding History

Walleye Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Buy
79,300
+3,950
+5% +$762K 0.03% 593
2025
Q4 		$13.9M Buy
75,350
+1,250
+2% +$219K 0.02% 775
2025
Q3 		$11.4M Sell
74,100
-12,250
-14% -$1.85M 0.02% 835
2025
Q2 		$12.1M Buy
86,350
+47,250
+121% +$6.62M 0.02% 720
2025
Q1 		$5.75M Sell
39,100
-116,200
-75% -$16.8M 0.01% 1002
2024
Q4 		$20.4M Buy
155,300
+34,000
+28% +$4.76M 0.04% 472
2024
Q3 		$18.9M Sell
121,300
-127,700
-51% -$20.6M 0.04% 489
2024
Q2 		$38.8M Sell
249,000
-17,450
-7% -$2.63M 0.09% 222
2024
Q1 		$36.1M Buy
266,450
+7,400
+3% +$980K 0.08% 240
2023
Q4 		$34.9M Buy
259,050
+96,100
+59% +$12.5M 0.08% 251
2023
Q3 		$22.1M Sell
162,950
-36,650
-18% -$5.01M 0.06% 336
2023
Q2 		$28.6M Buy
199,600
+140,800
+239% +$20.7M 0.09% 201
2023
Q1 		$8.16M Sell
58,800
-5,600
-9% -$753K 0.02% 724
2022
Q4 		$8.73M Sell
64,400
-45,050
-41% -$5.65M 0.02% 741
2022
Q3 		$12M Buy
109,450
+73,800
+207% +$9.36M 0.04% 531
2022
Q2 		$4.71M Sell
35,650
-17,854
-33% -$2.34M 0.02% 1076
2022
Q1 		$7.1M Buy
53,504
+19,130
+56% +$2.29M 0.02% 793
2021
Q4 		$4M Sell
34,374
-20,034
-37% -$2.36M 0.01% 1123
2021
Q3 		$6.54M Buy
54,408
+26,058
+92% +$3.03M 0.02% 780
2021
Q2 		$3.4M Buy
28,350
+26,600
+1,520% +$2.92M 0.01% 1067
2021
Q1 		$174K Sell
1,750
-19,850
-92% -$2M ﹤0.01% 3742
2020
Q4 		$2.16M Sell
21,600
-7,000
-24% -$741K 0.01% 1336
2020
Q3 		$3.13M Sell
28,600
-32,200
-53% -$3.58M 0.02% 839
2020
Q2 		$6.43M Buy
60,800
+29,800
+96% +$3.08M 0.04% 424
2020
Q1 		$2.77M Buy
31,000
+1,400
+5% +$132K 0.02% 647
2019
Q4 		$2.95M Buy
29,600
+5,150
+21% +$485K 0.02% 922
2019
Q3 		$2.18M Buy
24,450
+12,050
+97% +$1.04M 0.02% 964
2019
Q2 		$1.02M Sell
12,400
-2,750
-18% -$216K 0.01% 1581
2019
Q1 		$1.23M Sell
15,150
-2,650
-15% -$209K 0.01% 1478
2018
Q4 		$1.35M Buy
17,800
+12,500
+236% +$976K 0.01% 1400
2018
Q3 		$419K Buy
5,300
+350
+7% +$26.5K ﹤0.01% 3080
2018
Q2 		$348K Sell
4,950
-14,650
-75% -$1.05M ﹤0.01% 3160
2018
Q1 		$1.37M Sell
19,600
-46,950
-71% -$3.25M 0.01% 1605
2017
Q4 		$4.62K Buy
66,550
+38,000
+133% +$2.56M 0.02% 718
2017
Q3 		$1.94K Buy
28,550
+3,850
+16% +$243K 0.01% 1294
2017
Q2 		$1.68K Sell
24,700
-17,750
-42% -$1.16M 0.01% 1309
2017
Q1 		$2.64K Buy
42,450
+34,850
+459% +$2.03M 0.02% 882
2016
Q4 		$416K Buy
7,600
+4,250
+127% +$241K ﹤0.01% 2226
2016
Q3 		$220K Sell
3,350
-6,100
-65% -$399K ﹤0.01% 2730
2016
Q2 		$568K Buy
9,450
+4,350
+85% +$253K ﹤0.01% 2096
2016
Q1 		$289K Sell
5,100
-18,650
-79% -$1.12M ﹤0.01% 2450
2015
Q4 		$1.61M Buy
23,750
+9,450
+66% +$620K 0.02% 896
2015
Q3 		$911K Buy
14,300
+13,100
+1,092% +$862K 0.01% 1127
2015
Q2 		$77K Buy
1,200
+600
+100% +$41.1K ﹤0.01% 3220
2015
Q1 		$42K Sell
600
-530,500
-100% -$36.9M ﹤0.01% 3196
2014
Q4 		$37.4M Buy
531,100
+513,400
+2,901% +$36.8M 0.34% 31
2014
Q3 		$1.26M Sell
17,700
-6,200
-26% -$454K 0.01% 690
2014
Q2 		$1.77K Buy
23,900
+21,300
+819% +$1.54M 0.02% 467
2014
Q1 		$168 Sell
2,600
-8,100
-76% -$523K ﹤0.01% 2032
2013
Q4 		$636K Buy
+10,700
New +$581K 0.01% 1404
2013
Q3 		– Sell
-5,300
Closed -$251K – 2915
2013
Q2 		$251K Buy
+5,300
New +$270K ﹤0.01% 1608

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Walleye Trading's AZN Position: Q1 2026 in Review

Walleye Trading reduced its AstraZeneca (AZN) stake by 91% in Q1 2026, selling an estimated $5.03M and leaving 2,657 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

Walleye Trading first reported a position in AZN in Q2 2013 and has held it in 23 quarters since. The position peaked at $9.54M in Q3 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Walleye Trading held 2,657 shares of AstraZeneca worth $524K as of Q1 2026.
  • Walleye Trading sold 26,102 AstraZeneca shares in Q1 2026, an estimated $5.03M.
  • AstraZeneca made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2565 holding.
  • Walleye Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 23 quarters since.
  • Walleye Trading's AstraZeneca position peaked at $9.54M in Q3 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.